MedPath

Surgery Without Neoadjuvant Chemoradiotherapy Compared With Neoadjuvant Chemoradiotherapy for Rectal Cancer With Negative Circumferential Resection Margin Based on MRI Assessment, a Perspective Multicenter Randomized Controlled Trial

Not Applicable
Conditions
Circumferential Resection Margin
Disease-free Survival
Overal Survival
Intraoperative Perforation of Rectum
Local Recurrence of Malignant Tumor of Rectum
Interventions
Other: neoadjuvant chemoradiotherapy
Registration Number
NCT03504449
Lead Sponsor
Beijing Chao Yang Hospital
Brief Summary

For now, neoadjuvant chemoradiotherapy is routinely performed for T3N1-2M0 rectal cancer. However, there are lots of complications following neoadjuvant chemoradiotherapy, such as Wound-related complications, anastomotic leakage, anastomotic stenosis, sexual dysfunction, testicular or ovary failure. Patients undergoing resection for rectal cancer had low rates of local recurrence and long disease-free survival regardless of whether an APR, CAA or low AR was performed. The main purpose of preoperative radiotherapy is to lower the local recurrence. For the T3N1-2M0 rectal cancer with negative circumferential resection margin based on MRI assessment, we suppose might not necessary to receive neoadjuvant chemoradiotherapy, for operation can achieve the negative circumferential resection margin.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
350
Inclusion Criteria
  1. Tumor within 12 cm of the anal verge
  2. T3N1-2 as determined by preoperative MRI examination
  3. negative circumferential resection margin determined by preoperative MRI examination
  4. Absence of distant metastases
  5. Absence of intestinal obstruction
Exclusion Criteria
  1. With distant metastases
  2. With intestinal obstruction
  3. Pregnancy or lactation
  4. With operation contraindication
  5. With mental disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
surgery with neoadjuvant chemoradiotherapyneoadjuvant chemoradiotherapyFor T3N1-2M0 rectal cancer with negative circumferential resection margin based on MRI assessment, recieve surgery following neoadjuvant chemoradiotherapy.
surgery without neoadjuvant chemoradiotherapyneoadjuvant chemoradiotherapyFor T3N1-2M0 rectal cancer with negative circumferential resection margin based on MRI assessment, recieve surgery without neoadjuvant chemoradiotherapy.
Primary Outcome Measures
NameTimeMethod
circumferential resection marginone week after operation
introperative perforationDuring the operation
Secondary Outcome Measures
NameTimeMethod
local recurrece3 years after operation
overal survival3 years after operation
disease-free survival3 years after operation
complications30 days after operation

Trial Locations

Locations (1)

Beijing Chaoyang Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath